Cristin-person-ID: 44157
Person

Anders Waage

  • Stilling:
    Seksjonsleder
    ved Medisinsk klinikk ved St. Olavs Hospital HF

Klassifisering

Vitenskapsdisipliner

Medisinske fag

Resultater Resultater

Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report.

Murray, David L.; Puig, Noemi; Kristinsson, Sigurður Y.; Usmani, Saad; Dispenzieri, Angela; Bianchi, Giada; Kumar, Shaji; Chng, Wee Joo; Hajek, Roman; Paiva, Bruno mfl.. 2021, Blood Cancer Journal. CS, USA, HÊ, STOLAV, Ou, NTNU, MAYO, SPANIA, CUN, HMS, NUoSVitenskapelig artikkel

Patterns of previous and secondary malignancies in patients with multiple myeloma.

Langseth, Øystein Olstad; Myklebust, Tor Åge; Johannessen, Tom Børge; Hjertner, Øyvind; Waage, Anders. 2021, European Journal of Haematology. HELSEMR, STOLAV, NTNU, KREFTREGVitenskapelig artikkel

Bystander memory T cells and IMiD/checkpoint therapy in multiple myeloma: A dangerous tango?

Sponaas, Anne-Marit; Waage, Anders; Vandsemb, Esten; Misund, Kristine; Børset, Magne; Sundan, Anders; Slørdahl, Tobias Schmidt; Standal, Therese. 2021, Frontiers in Immunology. STOLAV, NTNUVitenskapelig oversiktsartikkel/review

Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group.

Moreau, Philippe; Kumar, Shaji; San Miguel, Jesús; Davies, Faith E.; Zamagni, Elena; Bahlis, Nizar; Ludwig, Heinz; Mikhael, Joseph; Terpos, Evangelos; Schjesvold, Fredrik H. mfl.. 2021, The Lancet Oncology. UdP, HÊ, UdS, Ou, MAYO, FREIBURG, UoNMC, UH, UNILILLE, AMC, UCALGARY, EMC, UNIW, PORTUGAL, UoSF, HCB, DANAFARBER, MELB, LEEDSTH, OUS, UJwK, EU, INSERM, KINA, UKHE, UIO, AÜ, UoCSF, UdSdB, VGR, KAROLINSKA, NAVARRA, STOLAV, HUMV, AKHWIEN, HUH, AMIKMWP, USA, SU, VUA, CUitCoNY, UOA, BRASIL, RTSUONJ, UoAaB, KU, NYU, MGH, SSN, NUoS, CS, UFdRdJ, TYRKIA, PETERMAC, SVEITS, ICR, MCoW, TGEN, UdlR, UdN, UCLVitenskapelig oversiktsartikkel/review

Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.

Cavo, Michele; Gay, Francesca; Beksac, Meral; Pantani, Lucia; Petrucci, Maria T.; Dimopoulos, Meletios A; Dozza, Luca; van der Holt, Branno; Zweegman, Sonja; Oliva, Stefania mfl.. 2020, The Lancet Haematology. UMCN, UdSdT, UdSdU, NTNU, UdSdP, SUS, MUVB, UdSdMeRE, TUMORI, STOLAV, ÅRHUSSYKE, UKvP, UM, EMC, NEDERLAND, VUMC, UdSdB, ITALIA, UdSdCVitenskapelig artikkel
1 - 5 av 407 | Neste | Siste »